Cargando…

Promising Immune Treatment of Advanced Cutaneous Squamous Cell Carcinoma with Cemiplimab—Real-World Experience in the Global SARS-CoV-2 Pandemic

Cutaneous squamous cell carcinoma (cSCC) is the second most frequent non-melanoma skin cancer. The standard curative treatment is surgical resection, but the treatment of locally advanced and metastatic disease apart from radiotherapy is currently based on cemiplimab. Cemiplimab has demonstrated eff...

Descripción completa

Detalles Bibliográficos
Autores principales: Pabianek, Marta, Lesiak, Aleksandra, Nejc, Dariusz, Kuncman, Łukasz, Narbutt, Joanna, Skibińska, Małgorzata, Ciążyńska, Magdalena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9600858/
https://www.ncbi.nlm.nih.gov/pubmed/36290893
http://dx.doi.org/10.3390/curroncol29100616